Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.MaxCyte that specializes in high performance cell loading systems, has announced the production of gram-scale quantities of proteins and antibodies from CHO cells using the MaxCyte STX Scalable Transfection System.
Subscribe to our email newsletter
The MaxCyte STX can transfect from 5E5 to 1E10 cells with comparable results from small bench scale through screening and cGMP manufacturing.
MaxCyte STX demonstrated the potential to achieve gram-scale antibody and protein production in an appropriate biomanufacturing host cell line with a simple 20-30 minute transfection run, the company said.
MaxCyte CEO and President Douglas Doerfler said the company is happy to announce the gram-scale antibody and protein yields achieved by users of the MaxCyte STX in standard biomanufacturing cell lines like CHO.
"Companies are no longer limited to settling for surrogate or non-relevant systems like HEK in order to generate enough protein or antibody for the development and screening of therapeutic biopharmaceuticals," Doerfler added.